A Phase II study of M119102 for alopecia areata

A Phase II, open-label, uncontrolled, multicenter study to evaluate efficacy and safety of M119102 in patients with alopecia areata

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2061220077

Enrollment

Registered

2022-12-23

Start date

2023-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia Areata

Interventions

Apply an appropriate amount of M119102 to on the lesion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with alopecia areata 12 to 64 years old

Exclusion criteria

Exclusion criteria: 1)Individuals with a history or merger of hepatic, renal, cardiac and other cardiovascular, gastrointestinal, hematologic, blood, endocrine, respiratory, or other diseases considered inappropriate for paticipation in the clinical study. (2)Individuals who are judged to be unsuitable as subject by the principal (sub) investigator.

Design outcomes

Primary

Measure	Time frame
LAD,SALT	—

Contacts

Public Contact- Clinical Trials Information

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026